PTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prescient Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.065 AUD Market Closed

Market Cap: AU$68.3m

	Prescient Therapeutics Ltd ASX:PTX	AU
C	CBAK Energy Technology Inc F:B6JA	CN

Profitability Summary

Prescient Therapeutics Ltd's profitability score is 9/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-25 420%

Negative 3Y Average Operating Margin

-6 420%

Declining Operating Margin

-1 538% > -25 420%

Negative Net Margin

-25 387%

Negative 3Y Average Net Margin

-6 468%

Declining Net Margin

-1 526% > -25 387%

Negative Free Cash Flow Margin

-22 915%

Negative 3Y Average Free Cash Flow Margin

-6 044%

Declining Free Cash Flow Margin

-1 349% > -22 915%

Negative ROE

-54%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-148%

ROIC is Increasing

-156% > -118%

View All

Hide

Collapse

9 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.